You are here: Industry Insights > Development

News List

Akili, Shionogi to develop digital therapeutics in key Asian markets biospectrumasia
March 11, 2019
Akili Interactive and Shionogi & Co. have announced that they have entered into a strategic partnership for the commercialization of Akili’s digital medicines, AKL-T01 and AKL-T02, in Japan and Taiwan, China region in China.
ICT Opens US Office & Announces Executive Appointments contractpharma
March 08, 2019
Office to launch in Rockville, Maryland, with the new hires heading regulatory affairs, business development, and quality assurance.
Glenmark Appoints New Innovation Company CEO contractpharma
March 07, 2019
Dr. Alessandro Riva will lead the new company, which will be a wholly-owned subsidiary of Glenmark and based in Paramus, NJ
Adagene collaborates with NIH to discover novel CAR-T biospectrumasia
January 07, 2019
Adagene, Inc., an innovative antibody discovery and engineering company, announced collaboration with Dr. Richard Childs, Chief of the Laboratory of Transplantation Immunotherapy at the National...
Jubilant Appoints Director of Business Development contractpharma
December 27, 2018
Jubilant HollisterStier has named Mark Sassler as their new director of business development for the contract manufacturing and services division. Mr. Sassler will report to Lynn Allen, senior director
Bridge Bio, Daewoong Pharma to Develop New UC Treatment contractpharma
December 21, 2018
Bridge Biotherapeutics Inc., a biotech company headquartered in Seongnam, South Korea, has signed a license agreement with Daewoong Pharmaceutical Co., Ltd.
Lilly, Aduro Biotech in Immunotherapy Alliance contractpharma
December 20, 2018
Eli Lilly and Co. and Aduro Biotech, Inc. have entered a research collaboration and exclusive license agreement for Aduro's cGAS-STING Pathway Inhibitor program for the development of novel immunotherapies.
Lilly Acquires Hydra Biosciences’ Pain Asset contractpharma
December 18, 2018
Eli Lilly and Co. has entered an agreement with Hydra Biosciences to acquire all assets related to Hydra's preclinical program of TRPA1 antagonists, part of the Transient Receptor Potential (TRP) family of ion channels being studied for the potential trea
Rentschler Biopharma Buys U.S. Mfg. Site from Shire contractpharma
December 18, 2018
Rentschler Biopharma SE, a contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA.
Proteostasis & Genentech Sign Licensing Deal contractpharma
December 18, 2018
Proteostasis Therapeutics has entered a worldwide, exclusive license agreement with Genentech, a member of the Roche Group, for rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network.

Previous page 1 2 3 4 5 6 7 Next page